Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis.

Fred F. Kadlubar(Courtauld Institute of Art), Nicholas P. Lang(John L. McClellan Memorial Veterans Hospital), Keith R. Kaderlik(National Center for Toxicological Research), Marguerite A. Butler(National Center for Toxicological Research), Hong‐Nong Chou(National Center for Toxicological Research)
Environmental Health Perspectives
November 1, 1992
10.1289/ehp.929869
Cited by 230

Related Papers

Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines.
|Proceedings of the National Academy of Sciences|1989|638
Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites
|Pharmacogenetics|1992|418
Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps.
|PubMed|1994|392
Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon
|Carcinogenesis|1991|342
Hepatic microsomal N-glucuronidation and nucleic acid binding of N-hydroxy arylamines in relation to urinary bladder carcinogenesis.
|PubMed|1977|325